List of Tables
Table 1. Global Point-of-care Testing (POCT) for Infectious Diseases Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Point-of-care Testing (POCT) for Infectious Diseases Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Point-of-care Testing (POCT) for Infectious Diseases Market Competitive Situation by Manufacturers in 2024
Table 4. Global Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Point-of-care Testing (POCT) for Infectious Diseases Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Point-of-care Testing (POCT) for Infectious Diseases, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Point-of-care Testing (POCT) for Infectious Diseases, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Point-of-care Testing (POCT) for Infectious Diseases, Product Type & Application
Table 12. Global Key Manufacturers of Point-of-care Testing (POCT) for Infectious Diseases, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Point-of-care Testing (POCT) for Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Testing (POCT) for Infectious Diseases as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Point-of-care Testing (POCT) for Infectious Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Point-of-care Testing (POCT) for Infectious Diseases Sales by Region (2020-2025) & (K Units)
Table 18. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Region (2020-2025)
Table 19. Global Point-of-care Testing (POCT) for Infectious Diseases Sales by Region (2026-2031) & (K Units)
Table 20. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Region (2026-2031)
Table 21. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Region (2020-2025)
Table 23. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Region (2026-2031)
Table 25. North America Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2020-2025) & (K Units)
Table 27. North America Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2026-2031) & (K Units)
Table 28. North America Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2020-2025) & (K Units)
Table 32. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2026-2031) & (K Units)
Table 33. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Point-of-care Testing (POCT) for Infectious Diseases Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Point-of-care Testing (POCT) for Infectious Diseases Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Point-of-care Testing (POCT) for Infectious Diseases Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units) by Type (2020-2025)
Table 51. Global Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units) by Type (2026-2031)
Table 52. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2020-2025)
Table 53. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2026-2031)
Table 54. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Type (2020-2025)
Table 57. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Type (2026-2031)
Table 58. Global Point-of-care Testing (POCT) for Infectious Diseases Price (US$/Unit) by Type (2020-2025)
Table 59. Global Point-of-care Testing (POCT) for Infectious Diseases Price (US$/Unit) by Type (2026-2031)
Table 60. Global Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units) by Application (2020-2025)
Table 61. Global Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units) by Application (2026-2031)
Table 62. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2020-2025)
Table 63. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2026-2031)
Table 64. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Application (2020-2025)
Table 67. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Application (2026-2031)
Table 68. Global Point-of-care Testing (POCT) for Infectious Diseases Price (US$/Unit) by Application (2020-2025)
Table 69. Global Point-of-care Testing (POCT) for Infectious Diseases Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Point-of-care Testing (POCT) for Infectious Diseases Product
Table 74. Roche Recent Developments/Updates
Table 75. Abbott Company Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Abbott Point-of-care Testing (POCT) for Infectious Diseases Product
Table 79. Abbott Recent Developments/Updates
Table 80. Siemens Healthineers Company Information
Table 81. Siemens Healthineers Description and Business Overview
Table 82. Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Product
Table 84. Siemens Healthineers Recent Developments/Updates
Table 85. Danaher Company Information
Table 86. Danaher Description and Business Overview
Table 87. Danaher Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Danaher Point-of-care Testing (POCT) for Infectious Diseases Product
Table 89. Danaher Recent Developments/Updates
Table 90. BD Company Information
Table 91. BD Description and Business Overview
Table 92. BD Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. BD Point-of-care Testing (POCT) for Infectious Diseases Product
Table 94. BD Recent Developments/Updates
Table 95. Assure Tech Company Information
Table 96. Assure Tech Description and Business Overview
Table 97. Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Product
Table 99. Assure Tech Recent Developments/Updates
Table 100. BioMerieux Company Information
Table 101. BioMerieux Description and Business Overview
Table 102. BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Product
Table 104. BioMerieux Recent Developments/Updates
Table 105. Bio-Rad Laboratories Company Information
Table 106. Bio-Rad Laboratories Description and Business Overview
Table 107. Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Product
Table 109. Bio-Rad Laboratories Recent Developments/Updates
Table 110. Wondfo Company Information
Table 111. Wondfo Description and Business Overview
Table 112. Wondfo Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Wondfo Point-of-care Testing (POCT) for Infectious Diseases Product
Table 114. Wondfo Recent Developments/Updates
Table 115. Wuhan Easy Diagnosis Company Information
Table 116. Wuhan Easy Diagnosis Description and Business Overview
Table 117. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Product
Table 119. Wuhan Easy Diagnosis Recent Developments/Updates
Table 120. Getein Biotech Company Information
Table 121. Getein Biotech Description and Business Overview
Table 122. Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Product
Table 124. Getein Biotech Recent Developments/Updates
Table 125. Beijing Hotgen Biotech Co.,ltd. Company Information
Table 126. Beijing Hotgen Biotech Co.,ltd. Description and Business Overview
Table 127. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Product
Table 129. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
Table 130. Beijing Wantai BioPharm Company Information
Table 131. Beijing Wantai BioPharm Description and Business Overview
Table 132. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Product
Table 134. Beijing Wantai BioPharm Recent Developments/Updates
Table 135. Zhejiang Orient Gene Biotech Co.,Ltd. Company Information
Table 136. Zhejiang Orient Gene Biotech Co.,Ltd. Description and Business Overview
Table 137. Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Product
Table 139. Zhejiang Orient Gene Biotech Co.,Ltd. Recent Developments/Updates
Table 140. Sansure Biotech Inc. Company Information
Table 141. Sansure Biotech Inc. Description and Business Overview
Table 142. Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Product
Table 144. Sansure Biotech Inc. Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Point-of-care Testing (POCT) for Infectious Diseases Distributors List
Table 148. Point-of-care Testing (POCT) for Infectious Diseases Customers List
Table 149. Point-of-care Testing (POCT) for Infectious Diseases Market Trends
Table 150. Point-of-care Testing (POCT) for Infectious Diseases Market Drivers
Table 151. Point-of-care Testing (POCT) for Infectious Diseases Market Challenges
Table 152. Point-of-care Testing (POCT) for Infectious Diseases Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Point-of-care Testing (POCT) for Infectious Diseases
Figure 2. Global Point-of-care Testing (POCT) for Infectious Diseases Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Point-of-care Testing (POCT) for Infectious Diseases Market Share by Type: 2024 & 2031
Figure 4. Based on Colloidal Gold Product Picture
Figure 5. Based on Chemiluminescence Product Picture
Figure 6. Based on Fluorescence Immunochromatography Product Picture
Figure 7. Other Product Picture
Figure 8. Global Point-of-care Testing (POCT) for Infectious Diseases Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Point-of-care Testing (POCT) for Infectious Diseases Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. lndependent Testing Organization
Figure 12. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Point-of-care Testing (POCT) for Infectious Diseases Market Size (2020-2031) & (US$ Million)
Figure 14. Global Point-of-care Testing (POCT) for Infectious Diseases Sales (2020-2031) & (K Units)
Figure 15. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price (US$/Unit) & (2020-2031)
Figure 16. Point-of-care Testing (POCT) for Infectious Diseases Report Years Considered
Figure 17. Point-of-care Testing (POCT) for Infectious Diseases Sales Share by Manufacturers in 2024
Figure 18. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Point-of-care Testing (POCT) for Infectious Diseases Players: Market Share by Revenue in Point-of-care Testing (POCT) for Infectious Diseases in 2024
Figure 20. Point-of-care Testing (POCT) for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Point-of-care Testing (POCT) for Infectious Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country (2020-2031)
Figure 23. North America Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country (2020-2031)
Figure 24. United States Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country (2020-2031)
Figure 27. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country (2020-2031)
Figure 28. Germany Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Region (2020-2031)
Figure 35. China Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country (2020-2031)
Figure 43. Latin America Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Point-of-care Testing (POCT) for Infectious Diseases by Type (2020-2031)
Figure 53. Global Revenue Market Share of Point-of-care Testing (POCT) for Infectious Diseases by Type (2020-2031)
Figure 54. Global Point-of-care Testing (POCT) for Infectious Diseases Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Point-of-care Testing (POCT) for Infectious Diseases by Application (2020-2031)
Figure 56. Global Revenue Market Share of Point-of-care Testing (POCT) for Infectious Diseases by Application (2020-2031)
Figure 57. Global Point-of-care Testing (POCT) for Infectious Diseases Price (US$/Unit) by Application (2020-2031)
Figure 58. Point-of-care Testing (POCT) for Infectious Diseases Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
